Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Doripenem (Doribax)

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Doripenem - DORIBAX™ (opens in a new tab)Original source URL: https://globalrph.com/dilution/doripenem/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/doripenem/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:45:32.909281+00:00
Source location
div.post-content
Packaged content SHA-256
32ec0ed497dbf4e0f3f5dd62f918348edeff49605e2709433d13dbc411b7f456
Original response SHA-256
5e12833cc327c74f2218292d783cff72e3ed2393cc34a22e5838f9dcfc9b543f
Source body SHA-256
21bc8113ab7c91fd8d72a75779a61adddfbeda00a32cae0f1d01aafa8887a42d

Doripenem - DORIBAX™

The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents

NS, D5W

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]

[ 500 mg ] [ 100 ml ] [ 1 hour ]
(Total volume: 110 ml)

[ 250 mg ] [ 50 ml ] [ 1 hour ]
(Total volume: 55 ml)

Reconstitute the 500 mg vial with 10 mL of sterile water or 0.9% NS.

Stability / Miscellaneous

Stability data:

Drug Stability
Refrigerated
Stability
Room Temp.
Reconstituted
Vial/Powder
Notes
Doripenem Infusion prepared in || Stability time at 2-8°C (Refrigeration) (includes refrigerator storage and infusion time)

Normal saline - 72 hrs

5% Dextrose - 24 hours

DORIBAX® should be stored at 25°C (77°F); excursions permitted to 15°-30°C (59° to 86°F)

Infusion prepared in | Stability Time at Room Temp. (includes room temperature storage and infusion time)

Normal saline - 12 hours

5% Dextrose - 4 hours

Powder The compatibility of DORIBAX® with other drugs has not been established. DORIBAX® should not be mixed with or physically added to solutions containing other drugs.

Do not freeze.


DOSAGE AND ADMINISTRATION:

500 mg every 8 hours by intravenous infusion administered over one hour for
patients ≥18 years of age.

Renal Dosing:

Separate renal reference: Open Renal Dosing Master (opens in a new tab)
CrCl (mL/min)  Recommended Dose
>50 No dosage adjustment necessary
≥ 30 to ≤ 50  250 mg IV (over 1 hour) every 8 hours
>10 to < 30 250 mg IV (over 1 hour) every 12 hours
HemodialysisSeparate renal reference: Open Renal Dosing Master (opens in a new tab) DORIBAX™ is hemodialyzable; however, there is insufficient information to make
dose adjustment recommendations in patients on hemodialysis

PREPARATION:
DORIBAX does not contain a bacteriostatic preservative. Aseptic technique must be followed in preparation of the infusion solution.
Preparation of 500 mg dose: Constitute the vial with 10 mL of sterile water for injection or 0.9% sodium chloride injection (normal saline) and gently shake to form a suspension. The resultant concentration is 50 mg/mL. CAUTION: THE CONSTITUTED SUSPENSION IS NOT FOR DIRECT INJECTION. Withdraw the suspension using a syringe with a 21 gauge needle and add it to an infusion bag containing 100 mL of normal saline or 5% dextrose; gently shake until clear. The final infusion solution concentration is 4.5 mg/mL.

Preparation of 250 mg dose for patients with moderate or severe renal impairment: Constitute the vial with 10 mL of sterile water for injection or 0.9% sodium chloride injection (normal saline) and gently shake to form a suspension. The resultant concentration is 50 mg/mL. CAUTION: THE CONSTITUTED SUSPENSION IS NOT FOR DIRECT INJECTION. Withdraw the suspension using a syringe with a 21 gauge needle and add it to an infusion bag containing 100 mL of normal saline or 5% dextrose; gently shake until clear. Remove 55 mL of this solution from the bag and discard. Infuse the remaining solution, which contains 250 mg (4.5 mg/mL).

STABILITY:
Storage of Constituted Solutions
Upon constitution with sterile water for injection or 0.9% sodium chloride (normal
saline) injection, DORIBAX suspension in the vial may be held for 1-hour prior to
transfer and dilution in the infusion bag. Following dilution of the suspension with normal saline or 5% dextrose, DORIBAX infusions stored at controlled room temperature or under refrigeration should be completed according to the times in the following table:

Infusion prepared in: Stability at room temp Stability if refrigerated
Normal saline 12 hours 72 hours
D5W 4 hours 24 hours

Source: Ortho-McNeil Pharmaceutical, Inc. (Manufactured by:Shionogi & Co. Ltd). Doripenem (DORIBAX™) [package insert]. Raritan, NJ 08869; 2007.

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
adjustment_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        class_level
        Provenance classification
        historical_class_level
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      doripenem-doribax
      Source IDH51-F3BB8E45B5045E9F089DAA41
      Generic name
      Doripenem (Doribax)
      Source IDH51-F42E6219662CAC185D1A1673
      Class
      Antibacterial
      Source IDH51-6E5CFEDF248CD487CE2571A0
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-B9DCE7AD33F2152A648F25D6
      Primary uses
      1. Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use.
        Source IDH51-C91B5C798BBF8F761C555387
      Mechanism
      Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis.
      Source IDH51-36CBA78334338E01E09C1924
      Mechanism level
      class_level
      Source IDH51-5A17C1B8575554623021EEFC
      Basic dosing orientation
      The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy.
      Source IDH51-B45DC4A07A54987119C59C6C
      Administration orientation
      Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required.
      Source IDH51-EC55FD85FC55BE7B39A64091
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
      Source IDH51-06A80374E16C8E70431F2221
      Key safety orientation
      1. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-650EC6789EE7BDA901BB5839
      Coverage path
      automatic_legacy_quick_reference
      Source IDH51-48297407B613427D9B26ACBA
      Coverage path label
      Automatic legacy GlobalRPh quick reference
      Source IDH51-2E025F4E0A9833779AABC9C7
      Legacy title
      Doripenem (Doribax)
      Source IDH51-D6800649DA51515F70524C49
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-F16206B00E02D3A5B6E86302
      Search text
      Doripenem (Doribax) Antibacterial Legacy GlobalRPh directory entry Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use. Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis. The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy. Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required. Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Automatic legacy GlobalRPh quick reference
      Source IDH51-1545D7601706E8446748075F
      Official access mode
      search
      Source IDH51-7E4E14C05028BA771A07CFAC
      Official search query
      Doripenem (Doribax)
      Source IDH51-08BC52F436D3BAB429A0903B
      Official access reason
      A source-backed DailyMed search is available; select and confirm the exact IV product.
      Source IDH51-D0E928852AC7A2D01E975D7C

      No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      adjustment_required
      Source IDH51-3A6CD5AC0B265D3EBEE16342
      Summary
      Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
      Source IDH51-DDFB38C82DB0E8EE257920FE
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-A1339CC9DFCD76637FA921F3

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-EF330FFB269D3D901E25421C

      Historical Stability notes

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy product stability information is not automatically equivalent to a USP <797> BUD.
        Source IDH51-0018E5403EC9CDDCE18468B8

      Historical supplemental professional sources

      Recovered v5.1 source content; historical, awaiting current review.

      LabelUrlKind
      Source IDH51-32F29566CCA954E83EA16E2A
      UCSF adult antimicrobial dosing, non-dialysis
      Source IDH51-152EABEC4827C8FBE0E0AA55
      https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)
      Source IDH51-334B208B72FB7BDC3AAAE308
      Professional institutional guidance
      Source IDH51-628061F8D7776E1E51D6A905
      Source IDH51-50AEC321B5E87171B8D42DE2
      UCSF antimicrobial dosing in intermittent and continuous hemodialysis
      Source IDH51-8AAC96AB6E8B5944345AC69A
      https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)
      Source IDH51-8F6EBDB011CE225458F3D58F
      Professional institutional guidance
      Source IDH51-A806B43C1A41FC72F8598CC2
      Source IDH51-714885032379591B7A9051B9
      UCSF pediatric antimicrobial dosing
      Source IDH51-4FE9F7BA2A01832EED5CC7AE
      https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-677B6F06B5FA1BE8A87ED7FA
      Professional institutional guidance
      Source IDH51-493D4249AD22E0C4A28AF203
      Source IDH51-8668CC2C17286461C61DB8F2
      UCSF neonatal antimicrobial dosing
      Source IDH51-F28F588C98DE0B25FD94C0CE
      https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-E2AD7CF7744E1559E5BF3B88
      Professional institutional guidance
      Source IDH51-2769CB37CD0D0528222A700E
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      doripenem-doribax
      Source IDH51-515B92D1FAEC47DBD4156189
      Legacy title
      Doripenem (Doribax)
      Source IDH51-DECEA296D6C60D43A20DAB43
      Generic name
      Doripenem (Doribax)
      Source IDH51-D3DDD4CFD835BE4CEF8D1061
      Class
      Antibacterial
      Source IDH51-9BD46AC26B4FB6E06971E977
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-04652308D7A88701B33C24ED
      Summary
      Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.
      Source IDH51-FFF495788014EDBA21EA66E0
      Populations
      1. Population not yet normalized
        Source IDH51-A22AB8C06B0AF1C69148ACF9
      Evidence tier
      Legacy catalog - migration review required
      Source IDH51-49CE73E50D1810E360F8AB23
      High alert
      false
      Source IDH51-1DE381475A0AD75E24CFF277
      Hazardous
      false
      Source IDH51-E406D1FB081498E299692796
      Status
      Legacy migration
      Source IDH51-BA9E3A8D0B68F7E4B5F80854
      Version added
      Legacy
      Source IDH51-5C2DEC75C72A9728926F4765
      Sources
      LabelUrlKind
      Source IDH51-18EC291E3B612ABB74A18B63
      GlobalRPh legacy IV dilution monograph
      Source IDH51-459B902E3000944345D0B9A2
      legacy:auto
      Source IDH51-F7DD2C2D1DC6E9BBF93506AC
      Legacy
      Source IDH51-25C2279DAF4C734239D866FE
      Clinical release verification
      Audit version
      3.4
      Source IDH51-2D4CD62EE08624239EB918E3
      Audited on
      2026-08-30
      Source IDH51-B88A194F759A944B78D6ED61
      Level
      amber
      Source IDH51-7E62A9010D05B3DD90B361AB
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-B87DB29D10079A365CA0E7C6
      Exact current label candidate
      false
      Source IDH51-56F598C1830B6C6CFFCA91EC
      Reference url count
      4
      Source IDH51-145AD006A1B376BF77EFDBE7
      Broken reference count
      0
      Source IDH51-9632619F109FEAD08C051718
      Point of use confirmation required
      true
      Source IDH51-1379BBC4ADCAC1AB0D197841
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-26A0F51942A5FF5EC37C0C2D

      Dosing source fields

      Id
      doripenem-doribax
      Source IDH51-AE8BC3667B4A61F85FBBF8E9
      Generic name
      Doripenem (Doribax)
      Source IDH51-11317B02C99306060F736C48
      Coverage status
      direct_official_label_access_plus_legacy_reference
      Source IDH51-009F366E056830CE52C7D8D8
      Package insert
      Query name
      Doripenem
      Source IDH51-21C13177BFB9426BA3CBB29A
      Product and route must match
      true
      Source IDH51-414C0CD5857A953E271F969D
      Live current label enabled
      false
      Source IDH51-190EC7AA4FB1E905C70E59DE
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-56FC5566E605DB9572F74BC8
      Direct official label access enabled
      true
      Source IDH51-CB0B78C5BEC1A17B659F4712
      Outbound server request required
      false
      Source IDH51-92238C898532707C4A5EF910
      Local summary status
      not_bundled
      Source IDH51-39B137CD7933535072AF6C0D
      Clinical review
      Locally normalized
      false
      Source IDH51-561A98B0424BEB062940F13F
      Reviewed
      2026-08-29
      Source IDH51-A4B3837C1EBA62B6F39F97D5
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-7C5E04186B58A5FDCCE18D45
      Clinical release verification
      Audit version
      3.4
      Source IDH51-010021080CE22D045C59B35D
      Audited on
      2026-08-30
      Source IDH51-DAC51009F3C1B28261B2CA68
      Level
      amber
      Source IDH51-A9604B190018CC19DCEA176C
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-14AC6B803EFDBA0A2FFC518D
      Exact current label candidate
      false
      Source IDH51-4B1EEFD3AF71638A971B0F1A
      Reference url count
      4
      Source IDH51-EE4FED365CBEC9894F07378D
      Broken reference count
      0
      Source IDH51-4B68842B25F2E9CAB26BDA28
      Point of use confirmation required
      true
      Source IDH51-B7F0D0471C9757D8B48016A8
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-C2E7B1A297EA2A63D588D284
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      doripenem-doribax
      Source IDH51-CB0113413209E02753D6B11B
      Name
      Doripenem (Doribax)
      Source IDH51-7B7293A81A708AFB2C514380
      Therapeutic class
      Antibacterial
      Source IDH51-7D47CF9C917A2E0E366ABEA0
      Review version
      3.1
      Source IDH51-A352C23C6A4CF424B05BB4DB
      Review date
      2026-08-30
      Source IDH51-C54FC6109051373638AAFD80
      Release status
      no_released_dilution_current_label_review_required
      Source IDH51-B584D291919757D320285696
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-7152282A5F4E6B86FD8CF37F
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-BA8970DB350811ED72B797C5
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-9DF42F01F142FF692DD2C8DB
      Reconstitution concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-0FDA38A163FCFBDA60DBB998
      Maximum or recommended final concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-395A0E992F6F9AEB80017AC8
      Appropriate standardized containers
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-712087DC32508EFE9F589B4E
      Adult dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-5495722145DD6577190D10D4
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-3C920A10EFAC9BD68E34B9E4
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-0B4ECA44ADD847E10876FF02
      Infusion time
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-52D930DA680B9DB0817AD9F2
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-E0A71504471DDF456F35134A
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-CD782B36C1727958B6B8A1F8
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-0CCD56DCC641932247278F6B
      Reconstitution concentration
      Primary
      not_found
      Source IDH51-F757052CF573B90CDEBFFDD3
      Maximum or recommended final concentration
      Primary
      not_found
      Source IDH51-8276F4B55C0D5091FA339B0B
      Appropriate standardized containers
      Primary
      not_found
      Source IDH51-20B2C8C46A091DE12BDCF7D8
      Adult dosing range
      Primary
      not_found
      Source IDH51-D51D7D7952AD5274B463338A
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-7EBE39372D0E46BB3F70041C
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-6E16D72F15F2C2F0843D5FB9
      Infusion time
      Primary
      not_found
      Source IDH51-98602B27B93E24EF0157260F
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-B9866E6945F1F6D77D81EFFE
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-C8152A493AA53BF87816F4B9
      Population applicability
      Adult
      Applicability
      not_established
      Source IDH51-55492B5CB4D0D035EB254238
      Guide generation allowed
      false
      Source IDH51-8C3A8E852BE723540BF5166C
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-7E1CFB77AEBE0CBA0BE83A03
      Guide generation allowed
      false
      Source IDH51-7CCBC1F1155010F7A83CD5B3
      Neonatal
      Applicability
      supported_or_source_present
      Source IDH51-16B66659575302C73A236F02
      Guide generation allowed
      false
      Source IDH51-5E913A5CD75A2C5A4E7AC45B
      Route presence
      Structured dilution
      false
      Source IDH51-3F55B0930F6380711E579498
      Iv push
      false
      Source IDH51-FD77FE8EF77D403232F1CC78
      Continuous infusion
      false
      Source IDH51-680BBDD8A35A2361BB98A1B7
      Pediatric source
      true
      Source IDH51-CEFB00EB4EB0B0698267ABC1
      Neonatal source
      true
      Source IDH51-55BFDB83445113785A6B9CBE
      Legacy reference
      Status
      not_available
      Source IDH51-BD640A59904AF9C95142CDAD
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-DDD92F528EE044EE59CE9151
      Source files
      1. catalog.json
        Source IDH51-D8E094D20AEBCF1E387AA1A9
      2. dosing.json
        Source IDH51-B11794E71A0B40C47687B253
      3. legacy-map.json
        Source IDH51-D7E534272FE06651722696BF
      4. review-queue.json
        Source IDH51-FCBDFFE911D359E8637EEC92
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-85F59DB7A4B85799C5CD3DC0
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-515B92D1FAEC47DBD4156189catalog.json
      /records/85/id
      Historical; current review incomplete
      H51-DECEA296D6C60D43A20DAB43catalog.json
      /records/85/legacy_title
      Historical; current review incomplete
      H51-D3DDD4CFD835BE4CEF8D1061catalog.json
      /records/85/generic_name
      Historical; current review incomplete
      H51-9BD46AC26B4FB6E06971E977catalog.json
      /records/85/class
      Historical; current review incomplete
      H51-04652308D7A88701B33C24EDcatalog.json
      /records/85/subclass
      Historical; current review incomplete
      H51-FFF495788014EDBA21EA66E0catalog.json
      /records/85/summary
      Historical; current review incomplete
      H51-EF330FFB269D3D901E25421Ccatalog.json
      /records/85/warnings/0
      Historical; current review incomplete
      H51-0018E5403EC9CDDCE18468B8catalog.json
      /records/85/stability_notes/0
      Historical; current review incomplete
      H51-A22AB8C06B0AF1C69148ACF9catalog.json
      /records/85/populations/0
      Historical; current review incomplete
      H51-49CE73E50D1810E360F8AB23catalog.json
      /records/85/evidence_tier
      Historical; current review incomplete
      H51-1DE381475A0AD75E24CFF277catalog.json
      /records/85/high_alert
      Historical; current review incomplete
      H51-E406D1FB081498E299692796catalog.json
      /records/85/hazardous
      Historical; current review incomplete
      H51-BA9E3A8D0B68F7E4B5F80854catalog.json
      /records/85/status
      Historical; current review incomplete
      H51-619EB8108A3FD7E7C1ECDC65catalog.json
      /records/85/reviewed
      Historical; current review incomplete
      H51-5C2DEC75C72A9728926F4765catalog.json
      /records/85/version_added
      Historical; current review incomplete
      H51-18EC291E3B612ABB74A18B63catalog.json
      /records/85/sources/0
      Historical; current review incomplete
      H51-459B902E3000944345D0B9A2catalog.json
      /records/85/sources/0/label
      Historical; current review incomplete
      H51-F7DD2C2D1DC6E9BBF93506ACcatalog.json
      /records/85/sources/0/url
      Historical; current review incomplete
      H51-25C2279DAF4C734239D866FEcatalog.json
      /records/85/sources/0/kind
      Historical; current review incomplete
      H51-2D4CD62EE08624239EB918E3catalog.json
      /records/85/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-B88A194F759A944B78D6ED61catalog.json
      /records/85/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-7E62A9010D05B3DD90B361ABcatalog.json
      /records/85/clinical_release_verification/level
      Historical; current review incomplete
      H51-B87DB29D10079A365CA0E7C6catalog.json
      /records/85/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-56F598C1830B6C6CFFCA91ECcatalog.json
      /records/85/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-1C11628AA0BDD06D4A291530catalog.json
      /records/85/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-F129E833C4F7789BBFDA4BFBcatalog.json
      /records/85/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-73554401DFD84A7C1C44F319catalog.json
      /records/85/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-145AD006A1B376BF77EFDBE7catalog.json
      /records/85/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-9632619F109FEAD08C051718catalog.json
      /records/85/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-1379BBC4ADCAC1AB0D197841catalog.json
      /records/85/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-26A0F51942A5FF5EC37C0C2Dcatalog.json
      /records/85/clinical_release_verification/note
      Historical; current review incomplete
      H51-FD5ED69AB3E47C6152A73FE4catalog.json
      /records/85/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-AE8BC3667B4A61F85FBBF8E9dosing.json
      /records/85/id
      Historical; current review incomplete
      H51-11317B02C99306060F736C48dosing.json
      /records/85/generic_name
      Historical; current review incomplete
      H51-009F366E056830CE52C7D8D8dosing.json
      /records/85/coverage_status
      Historical; current review incomplete
      H51-21C13177BFB9426BA3CBB29Adosing.json
      /records/85/package_insert/query_name
      Historical; current review incomplete
      H51-6E8ED29EAA4C7F19330DD974dosing.json
      /records/85/package_insert/preferred_setid
      Historical; current review incomplete
      H51-414C0CD5857A953E271F969Ddosing.json
      /records/85/package_insert/product_and_route_must_match
      Historical; current review incomplete
      H51-190EC7AA4FB1E905C70E59DEdosing.json
      /records/85/package_insert/live_current_label_enabled
      Historical; current review incomplete
      H51-56FC5566E605DB9572F74BC8dosing.json
      /records/85/package_insert/source_priority
      Historical; current review incomplete
      H51-CB0B78C5BEC1A17B659F4712dosing.json
      /records/85/package_insert/direct_official_label_access_enabled
      Historical; current review incomplete
      H51-92238C898532707C4A5EF910dosing.json
      /records/85/package_insert/outbound_server_request_required
      Historical; current review incomplete
      H51-39B137CD7933535072AF6C0Ddosing.json
      /records/85/package_insert/local_summary_status
      Historical; current review incomplete
      H51-3A6CD5AC0B265D3EBEE16342dosing.json
      /records/85/renal/classification
      Historical; current review incomplete
      H51-DDFB38C82DB0E8EE257920FEdosing.json
      /records/85/renal/summary
      Historical; current review incomplete
      H51-A1339CC9DFCD76637FA921F3dosing.json
      /records/85/renal/method_note
      Historical; current review incomplete
      H51-32F29566CCA954E83EA16E2Adosing.json
      /records/85/professional_sources/0
      Historical; current review incomplete
      H51-152EABEC4827C8FBE0E0AA55dosing.json
      /records/85/professional_sources/0/label
      Historical; current review incomplete
      H51-334B208B72FB7BDC3AAAE308dosing.json
      /records/85/professional_sources/0/url
      Historical; current review incomplete
      H51-628061F8D7776E1E51D6A905dosing.json
      /records/85/professional_sources/0/kind
      Historical; current review incomplete
      H51-50AEC321B5E87171B8D42DE2dosing.json
      /records/85/professional_sources/1
      Historical; current review incomplete
      H51-8AAC96AB6E8B5944345AC69Adosing.json
      /records/85/professional_sources/1/label
      Historical; current review incomplete
      H51-8F6EBDB011CE225458F3D58Fdosing.json
      /records/85/professional_sources/1/url
      Historical; current review incomplete
      H51-A806B43C1A41FC72F8598CC2dosing.json
      /records/85/professional_sources/1/kind
      Historical; current review incomplete
      H51-714885032379591B7A9051B9dosing.json
      /records/85/professional_sources/2
      Historical; current review incomplete
      H51-4FE9F7BA2A01832EED5CC7AEdosing.json
      /records/85/professional_sources/2/label
      Historical; current review incomplete
      H51-677B6F06B5FA1BE8A87ED7FAdosing.json
      /records/85/professional_sources/2/url
      Historical; current review incomplete
      H51-493D4249AD22E0C4A28AF203dosing.json
      /records/85/professional_sources/2/kind
      Historical; current review incomplete
      H51-8668CC2C17286461C61DB8F2dosing.json
      /records/85/professional_sources/3
      Historical; current review incomplete
      H51-F28F588C98DE0B25FD94C0CEdosing.json
      /records/85/professional_sources/3/label
      Historical; current review incomplete
      H51-E2AD7CF7744E1559E5BF3B88dosing.json
      /records/85/professional_sources/3/url
      Historical; current review incomplete
      H51-2769CB37CD0D0528222A700Edosing.json
      /records/85/professional_sources/3/kind
      Historical; current review incomplete
      H51-561A98B0424BEB062940F13Fdosing.json
      /records/85/clinical_review/locally_normalized
      Historical; current review incomplete
      H51-A4B3837C1EBA62B6F39F97D5dosing.json
      /records/85/clinical_review/reviewed
      Historical; current review incomplete
      H51-7C5E04186B58A5FDCCE18D45dosing.json
      /records/85/clinical_review/status
      Historical; current review incomplete
      H51-010021080CE22D045C59B35Ddosing.json
      /records/85/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-DAC51009F3C1B28261B2CA68dosing.json
      /records/85/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-A9604B190018CC19DCEA176Cdosing.json
      /records/85/clinical_release_verification/level
      Historical; current review incomplete
      H51-14AC6B803EFDBA0A2FFC518Ddosing.json
      /records/85/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-4B1EEFD3AF71638A971B0F1Adosing.json
      /records/85/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-B029C0D257FE277B6E62A84Cdosing.json
      /records/85/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-4B76B5383477A75D42CA7605dosing.json
      /records/85/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-BEFA38CF2D33443B13998DF6dosing.json
      /records/85/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-EE4FED365CBEC9894F07378Ddosing.json
      /records/85/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-4B68842B25F2E9CAB26BDA28dosing.json
      /records/85/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-B7F0D0471C9757D8B48016A8dosing.json
      /records/85/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-C2E7B1A297EA2A63D588D284dosing.json
      /records/85/clinical_release_verification/note
      Historical; current review incomplete
      H51-32A329C73912F9F9ACE7E5D0dosing.json
      /records/85/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-F3BB8E45B5045E9F089DAA41first-look-v5.1.json
      /records/85/id
      Historical; current review incomplete
      H51-F42E6219662CAC185D1A1673first-look-v5.1.json
      /records/85/generic_name
      Historical; current review incomplete
      H51-6E5CFEDF248CD487CE2571A0first-look-v5.1.json
      /records/85/class
      Historical; current review incomplete
      H51-B9DCE7AD33F2152A648F25D6first-look-v5.1.json
      /records/85/subclass
      Historical; current review incomplete
      H51-C91B5C798BBF8F761C555387first-look-v5.1.json
      /records/85/primary_uses/0
      Historical; current review incomplete
      H51-36CBA78334338E01E09C1924first-look-v5.1.json
      /records/85/mechanism
      Historical; current review incomplete
      H51-5A17C1B8575554623021EEFCfirst-look-v5.1.json
      /records/85/mechanism_level
      Historical; current review incomplete
      H51-B45DC4A07A54987119C59C6Cfirst-look-v5.1.json
      /records/85/basic_dosing_orientation
      Historical; current review incomplete
      H51-EC55FD85FC55BE7B39A64091first-look-v5.1.json
      /records/85/administration_orientation
      Historical; current review incomplete
      H51-06A80374E16C8E70431F2221first-look-v5.1.json
      /records/85/renal_and_population_orientation
      Historical; current review incomplete
      H51-650EC6789EE7BDA901BB5839first-look-v5.1.json
      /records/85/key_safety_orientation/0
      Historical; current review incomplete
      H51-48297407B613427D9B26ACBAfirst-look-v5.1.json
      /records/85/coverage_path
      Historical; current review incomplete
      H51-2E025F4E0A9833779AABC9C7first-look-v5.1.json
      /records/85/coverage_path_label
      Historical; current review incomplete
      H51-16DB16C3466586B6648E3AD6first-look-v5.1.json
      /records/85/official_label_url
      Historical; current review incomplete
      H51-D6800649DA51515F70524C49first-look-v5.1.json
      /records/85/legacy_title
      Historical; current review incomplete
      H51-F16206B00E02D3A5B6E86302first-look-v5.1.json
      /records/85/review_note
      Historical; current review incomplete
      H51-1545D7601706E8446748075Ffirst-look-v5.1.json
      /records/85/search_text
      Historical; current review incomplete
      H51-654C83357D839CBFE103E0B9first-look-v5.1.json
      /records/85/official_search_url
      Historical; current review incomplete
      H51-7E4E14C05028BA771A07CFACfirst-look-v5.1.json
      /records/85/official_access_mode
      Historical; current review incomplete
      H51-1875979F7E78CC939AE44083first-look-v5.1.json
      /records/85/official_access_url
      Historical; current review incomplete
      H51-08BC52F436D3BAB429A0903Bfirst-look-v5.1.json
      /records/85/official_search_query
      Historical; current review incomplete
      H51-D0E928852AC7A2D01E975D7Cfirst-look-v5.1.json
      /records/85/official_access_reason
      Historical; current review incomplete
      H51-CB0113413209E02753D6B11Bpreparation-assessments-v3.8.json
      /85/id
      Historical; current review incomplete
      H51-7B7293A81A708AFB2C514380preparation-assessments-v3.8.json
      /85/name
      Historical; current review incomplete
      H51-FE5D1BFD024CE7CE5709331Apreparation-assessments-v3.8.json
      /85/brands
      Historical; current review incomplete
      H51-7D47CF9C917A2E0E366ABEA0preparation-assessments-v3.8.json
      /85/therapeutic_class
      Historical; current review incomplete
      H51-A352C23C6A4CF424B05BB4DBpreparation-assessments-v3.8.json
      /85/review_version
      Historical; current review incomplete
      H51-C54FC6109051373638AAFD80preparation-assessments-v3.8.json
      /85/review_date
      Historical; current review incomplete
      H51-B584D291919757D320285696preparation-assessments-v3.8.json
      /85/release_status
      Historical; current review incomplete
      H51-7152282A5F4E6B86FD8CF37Fpreparation-assessments-v3.8.json
      /85/market_status/status
      Historical; current review incomplete
      H51-BA8970DB350811ED72B797C5preparation-assessments-v3.8.json
      /85/market_status/basis
      Historical; current review incomplete
      H51-9DF42F01F142FF692DD2C8DBpreparation-assessments-v3.8.json
      /85/ten_point_assessment/exact_formulation
      Historical; current review incomplete
      H51-0FDA38A163FCFBDA60DBB998preparation-assessments-v3.8.json
      /85/ten_point_assessment/reconstitution_concentration
      Historical; current review incomplete
      H51-395A0E992F6F9AEB80017AC8preparation-assessments-v3.8.json
      /85/ten_point_assessment/maximum_or_recommended_final_concentration
      Historical; current review incomplete
      H51-712087DC32508EFE9F589B4Epreparation-assessments-v3.8.json
      /85/ten_point_assessment/appropriate_standardized_containers
      Historical; current review incomplete
      H51-5495722145DD6577190D10D4preparation-assessments-v3.8.json
      /85/ten_point_assessment/adult_dosing_range
      Historical; current review incomplete
      H51-3C920A10EFAC9BD68E34B9E4preparation-assessments-v3.8.json
      /85/ten_point_assessment/pediatric_dosing_range
      Historical; current review incomplete
      H51-0B4ECA44ADD847E10876FF02preparation-assessments-v3.8.json
      /85/ten_point_assessment/neonatal_dosing_range
      Historical; current review incomplete
      H51-52D930DA680B9DB0817AD9F2preparation-assessments-v3.8.json
      /85/ten_point_assessment/infusion_time
      Historical; current review incomplete
      H51-E0A71504471DDF456F35134Apreparation-assessments-v3.8.json
      /85/ten_point_assessment/fluid_restriction_alternatives
      Historical; current review incomplete
      H51-24AD38E166353CD3C2748BBEpreparation-assessments-v3.8.json
      /85/ten_point_assessment/current_manufacturer_labeling/setid
      Historical; current review incomplete
      H51-2A718467D21C142F1CF6CF15preparation-assessments-v3.8.json
      /85/ten_point_assessment/current_manufacturer_labeling/title
      Historical; current review incomplete
      H51-92B110779C7E8021F81221A2preparation-assessments-v3.8.json
      /85/ten_point_assessment/current_manufacturer_labeling/published_date
      Historical; current review incomplete
      H51-2E3436F4E878E86084879D25preparation-assessments-v3.8.json
      /85/ten_point_assessment/current_manufacturer_labeling/manufacturer
      Historical; current review incomplete
      H51-CD782B36C1727958B6B8A1F8preparation-assessments-v3.8.json
      /85/ten_point_assessment/current_manufacturer_labeling/match_confidence
      Historical; current review incomplete
      H51-B4C1930848B1D6A5F0D74DB1preparation-assessments-v3.8.json
      /85/ten_point_assessment/current_manufacturer_labeling/url
      Historical; current review incomplete
      H51-0CCD56DCC641932247278F6Bpreparation-assessments-v3.8.json
      /85/field_provenance/exact_formulation/primary
      Historical; current review incomplete
      H51-F757052CF573B90CDEBFFDD3preparation-assessments-v3.8.json
      /85/field_provenance/reconstitution_concentration/primary
      Historical; current review incomplete
      H51-8276F4B55C0D5091FA339B0Bpreparation-assessments-v3.8.json
      /85/field_provenance/maximum_or_recommended_final_concentration/primary
      Historical; current review incomplete
      H51-20B2C8C46A091DE12BDCF7D8preparation-assessments-v3.8.json
      /85/field_provenance/appropriate_standardized_containers/primary
      Historical; current review incomplete
      H51-D51D7D7952AD5274B463338Apreparation-assessments-v3.8.json
      /85/field_provenance/adult_dosing_range/primary
      Historical; current review incomplete
      H51-7EBE39372D0E46BB3F70041Cpreparation-assessments-v3.8.json
      /85/field_provenance/pediatric_dosing_range/primary
      Historical; current review incomplete
      H51-6E16D72F15F2C2F0843D5FB9preparation-assessments-v3.8.json
      /85/field_provenance/neonatal_dosing_range/primary
      Historical; current review incomplete
      H51-98602B27B93E24EF0157260Fpreparation-assessments-v3.8.json
      /85/field_provenance/infusion_time/primary
      Historical; current review incomplete
      H51-B9866E6945F1F6D77D81EFFEpreparation-assessments-v3.8.json
      /85/field_provenance/fluid_restriction_alternatives/primary
      Historical; current review incomplete
      H51-C8152A493AA53BF87816F4B9preparation-assessments-v3.8.json
      /85/field_provenance/current_manufacturer_labeling/primary
      Historical; current review incomplete
      H51-55492B5CB4D0D035EB254238preparation-assessments-v3.8.json
      /85/population_applicability/adult/applicability
      Historical; current review incomplete
      H51-8C3A8E852BE723540BF5166Cpreparation-assessments-v3.8.json
      /85/population_applicability/adult/guide_generation_allowed
      Historical; current review incomplete
      H51-7E1CFB77AEBE0CBA0BE83A03preparation-assessments-v3.8.json
      /85/population_applicability/pediatric/applicability
      Historical; current review incomplete
      H51-7CCBC1F1155010F7A83CD5B3preparation-assessments-v3.8.json
      /85/population_applicability/pediatric/guide_generation_allowed
      Historical; current review incomplete
      H51-16B66659575302C73A236F02preparation-assessments-v3.8.json
      /85/population_applicability/neonatal/applicability
      Historical; current review incomplete
      H51-5E913A5CD75A2C5A4E7AC45Bpreparation-assessments-v3.8.json
      /85/population_applicability/neonatal/guide_generation_allowed
      Historical; current review incomplete
      H51-3F55B0930F6380711E579498preparation-assessments-v3.8.json
      /85/route_presence/structured_dilution
      Historical; current review incomplete
      H51-FD77FE8EF77D403232F1CC78preparation-assessments-v3.8.json
      /85/route_presence/iv_push
      Historical; current review incomplete
      H51-680BBDD8A35A2361BB98A1B7preparation-assessments-v3.8.json
      /85/route_presence/continuous_infusion
      Historical; current review incomplete
      H51-CEFB00EB4EB0B0698267ABC1preparation-assessments-v3.8.json
      /85/route_presence/pediatric_source
      Historical; current review incomplete
      H51-55BFDB83445113785A6B9CBEpreparation-assessments-v3.8.json
      /85/route_presence/neonatal_source
      Historical; current review incomplete
      H51-BD640A59904AF9C95142CDADpreparation-assessments-v3.8.json
      /85/legacy_reference/status
      Historical; current review incomplete
      H51-DDD92F528EE044EE59CE9151preparation-assessments-v3.8.json
      /85/label_resolution/status
      Historical; current review incomplete
      H51-D8E094D20AEBCF1E387AA1A9preparation-assessments-v3.8.json
      /85/source_files/0
      Historical; current review incomplete
      H51-B11794E71A0B40C47687B253preparation-assessments-v3.8.json
      /85/source_files/1
      Historical; current review incomplete
      H51-D7E534272FE06651722696BFpreparation-assessments-v3.8.json
      /85/source_files/2
      Historical; current review incomplete
      H51-FCBDFFE911D359E8637EEC92preparation-assessments-v3.8.json
      /85/source_files/3
      Historical; current review incomplete
      H51-85F59DB7A4B85799C5CD3DC0preparation-assessments-v3.8.json
      /85/clinical_release_note
      Historical; current review incomplete